Cameron Health has developed the world’s first and only commercially available subcutaneous implantable cardioverter defibrillator – the S-ICD® System. “With Cameron, we gain a strong, experienced team of professionals who are pioneers in this novel technology, and we are thrilled to welcome them to Boston Scientific,” said Hank Kucheman, Chief Executive Officer of Boston Scientific. Click here for the full press release…